FR11C0040I1 - - Google Patents

Info

Publication number
FR11C0040I1
FR11C0040I1 FR11C0040C FR11C0040I1 FR 11C0040 I1 FR11C0040 I1 FR 11C0040I1 FR 11C0040 C FR11C0040 C FR 11C0040C FR 11C0040 I1 FR11C0040 I1 FR 11C0040I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of FR11C0040I1 publication Critical patent/FR11C0040I1/fr
Application granted granted Critical
Publication of FR11C0040I2 publication Critical patent/FR11C0040I2/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR11C0040C 1993-05-13 2011-09-13 METHOD FOR IN VITRO CULTURE OF DIFFERENT STAGES OF TISSUE PARASITES Active FR11C0040I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9305779A FR2705358B1 (en) 1993-05-13 1993-05-13 Method of in vitro culture of different stages of tissue parasites, parasitic stages obtained and biological applications.
PCT/FR1994/000577 WO1994026899A1 (en) 1993-05-13 1994-05-13 Method for the culture in vitro of differents stages of tissue parasites

Publications (2)

Publication Number Publication Date
FR11C0040I1 true FR11C0040I1 (en) 2011-10-14
FR11C0040I2 FR11C0040I2 (en) 2012-06-22

Family

ID=9447092

Family Applications (2)

Application Number Title Priority Date Filing Date
FR9305779A Expired - Lifetime FR2705358B1 (en) 1993-05-13 1993-05-13 Method of in vitro culture of different stages of tissue parasites, parasitic stages obtained and biological applications.
FR11C0040C Active FR11C0040I2 (en) 1993-05-13 2011-09-13 METHOD FOR IN VITRO CULTURE OF DIFFERENT STAGES OF TISSUE PARASITES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR9305779A Expired - Lifetime FR2705358B1 (en) 1993-05-13 1993-05-13 Method of in vitro culture of different stages of tissue parasites, parasitic stages obtained and biological applications.

Country Status (8)

Country Link
US (4) US6458581B1 (en)
EP (1) EP0698099B1 (en)
AU (1) AU6800094A (en)
CA (1) CA2162555C (en)
DE (2) DE69434424T2 (en)
ES (1) ES2245776T3 (en)
FR (2) FR2705358B1 (en)
WO (1) WO1994026899A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9503451A (en) * 1995-07-26 1997-09-30 Mendes Rodolfo Pereira Process of preparation of an antigen derived from a microorganism that causes infectious and / or parasitic disease Process of preparation of an antigen from T cruzi antigen derived from a microorganism that causes infectious disease and / or parasitic antigen derived from T cruzi that causes Chagas disease composition the base of an antigen derived from microorganism that causes infectious and / or parasitic disease composition the base of antigen from T cruzi use of the antigen derived from microorganism that causes infectious and / or parasitic disease in serological tests and vaccines use of antigen derived from T cruzi cause of chagas disease in serological tests and vaccines process for detecting antibodies against microorganism antigen causing infectious and / or parasitic disease and confirmatory serodiagnosis kit for infectious and / or parasitic disease
FR2825633B1 (en) * 2001-06-11 2005-12-16 Bio Veto Tests Bvt THERAPEUTIC VACCINE COMPLEX FOR THE PREVENTION AND TREATMENT OF LEISHMANIOSES AND INTRACELLULAR PATHOGENIC MICROORGANISM INFECTIONS IN MAMMALS
FR2863272B1 (en) * 2003-11-19 2006-06-09 Inst Rech Developpement Ird NEW MEANS FOR THE PREVENTION OF LEISHMANIOSES
FR2862313B1 (en) * 2003-11-19 2006-02-24 Inst Rech Developpement Ird NEW MEANS FOR THE PREVENTION OF LEISHMANIOSES
US20050176144A1 (en) * 2004-02-06 2005-08-11 O'daly Jose A. Culture media compositions free of fetal bovine serum
FR2881752B1 (en) 2005-02-10 2009-07-31 Inst Rech Pour Le Dev I R D Et MEANS FOR OBTAINING PROMASTIGOTS OF AVIRULENT, PROMASTIGIOUS LEISHANIES OBTAINED AND THEIR APPLICATIONS
DE102006041388A1 (en) * 2006-08-29 2008-03-20 Fachhochschule Jena Nutrient medium for culturing protozoa comprises yeast extract, phosphate, hemin and glucose
FR3014103B1 (en) 2013-11-29 2019-08-16 Institut De Recherche Pour Le Developpement (Ird) VACCINE COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF LEISHMANIOSES, IMMUNOGENIC PEPTIDES AND METHOD OF OBTAINING
FR3081870B1 (en) 2018-05-30 2024-04-19 Institut De Rech Pour Le Developpement Ird EPITOPES, MONO-OR MULTIEPITOPIC PEPTIDE COMPOUNDS AND VACCINES AGAINST LEISHMANIA
BR102018067339A2 (en) 2018-08-31 2021-11-16 Fundação Oswaldo Cruz METHOD FOR DETECTING ANTIBODIES AGAINST LEISHMANIA IN A CANINE BIOLOGICAL SAMPLE, KIT FOR DETECTION OF LEISHMANIA INFECTION IN A BIOLOGICAL SAMPLE, AND USE OF LEISHMANIA LIPOPHOSFOGLICAN

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US399743A (en) * 1889-03-19 Peters
FR1518449A (en) * 1967-04-12 1968-03-22 Vnii Antibiotikov Leishmania culture process
US3911097A (en) * 1973-08-07 1975-10-07 Research Corp Antigenic preparation suitable for diagnosis of chronic chagas disease
US3993743A (en) * 1973-08-07 1976-11-23 Research Corporation Method for diagnosis of Chagas' disease
IL67295A0 (en) * 1981-11-17 1983-03-31 Brigham & Womens Hospital Monoclonal antibodies against leishmania
DE3581288D1 (en) * 1984-10-01 1991-02-14 Pasteur Institut ANTILEISHMANIA MONOCLONAL ANTI-BODIES, THESE ANTI-BODY ELIMINATING HYBRIDOMAS, LEISHMANIA-ANTIGENS RECOGNIZED BY THESE ANTI-BODIES, METHODS FOR THE PRODUCTION AND USE OF THESE MONOCLONAL ANTI-ANODIERS AND ANTIBODIES.
US4687666A (en) * 1985-02-19 1987-08-18 Ministerio De Sanidad Y Asistencia Social Instituto Venezolano De Investigationes Cientificas Vaccine for Leishmaniasis
GB8921937D0 (en) * 1989-09-28 1989-11-15 Howard Michael K Diagnostic reagents for leishmaniasis
CA2115061A1 (en) * 1991-08-06 1993-02-18 David S. Sigman Method of isolation of dna
US5411865A (en) * 1993-01-15 1995-05-02 Iasys Corporation Method of detecting anti-leishmania parasite antibodies

Also Published As

Publication number Publication date
DE122011100046I1 (en) 2012-01-19
US20030059860A1 (en) 2003-03-27
EP0698099B1 (en) 2005-07-13
US7282210B2 (en) 2007-10-16
US20030138461A1 (en) 2003-07-24
US6458581B1 (en) 2002-10-01
FR2705358A1 (en) 1994-11-25
DE69434424D1 (en) 2005-08-18
FR2705358B1 (en) 1995-08-04
US20030068690A1 (en) 2003-04-10
CA2162555A1 (en) 1994-11-24
US7317094B2 (en) 2008-01-08
AU6800094A (en) 1994-12-12
DE69434424T2 (en) 2006-04-20
FR11C0040I2 (en) 2012-06-22
CA2162555C (en) 2011-07-12
WO1994026899A1 (en) 1994-11-24
ES2245776T3 (en) 2006-01-16
EP0698099A1 (en) 1996-02-28

Similar Documents

Publication Publication Date Title
FR2707024B1 (en)
EP0636970A3 (en)
FR11C0040I1 (en)
IN180820B (en)
DK0607839T3 (en)
DK144093D0 (en)
GB9420951D0 (en)
TW270126B (en)
FR2701860B1 (en)
NO941507D0 (en)
FR2706843B3 (en)
IN181204B (en)
IN178530B (en)
IN180644B (en)
IN179214B (en)
IN179127B (en)
GB9316971D0 (en)
IN177309B (en)
IN186023B (en)
IN187944B (en)
DK51093D0 (en)
DK122493D0 (en)
ECSDI930145S (en)
IN186396B (en)
IN186408B (en)